Danaher earnings were $3.5B for the trailing 12 months ending Sep 26, 2025, with -7.8% growth year over year. The latest DHR earnings report on Sep 26, 2025 announced Q3 2025 earnings of $908.0M, up 63.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DHR reported annual earnings of $3.9B, with -17.8% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q3 2025 earnings per share (EPS) of $1.28, up 13.27% year over year. Total DHR earnings for the quarter were $908.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $1.13.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Sep 26, 2025 was $3.50 billion, a 9.99% decrease year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown -7.75% year over year. This is 18.84 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 11.09%. DHR earnings in the past year totalled $3.50 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.